Related Experiment Videos
Factors affecting C3 in intestinal schistosomiasis
M M Hussein1, M M Ahmed, M Fayed
1Department of Tropical Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Journal of the Egyptian Society of Parasitology
|December 1, 1993
Summary
Complement component C3 (C3) levels are lower in individuals with schistosomiasis compared to healthy individuals. C3 levels were not significantly affected by Hepatitis B surface antigen (HBsAg) status or S. mansoni egg count.
Area of Science:
- Immunology
- Hepatology
- Parasitology
Background:
- Schistosomiasis is a parasitic disease affecting millions worldwide.
- Complement component C3 (C3) plays a crucial role in immune responses.
- Hepatitis B virus (HBV) infection is common in schistosomiasis-endemic areas.
Purpose of the Study:
- To investigate complement component C3 (C3) levels in patients with schistosomiasis.
- To explore the relationship between C3 levels, Schistosoma mansoni (S. mansoni) egg count, Hepatitis B surface antigen (HBsAg) presence, and liver function.
Main Methods:
- Serum C3 levels were measured in schistosomal patients without obvious nephritis.
- C3 levels were analyzed in relation to S. mansoni egg count, HBsAg status, and liver function tests.
- Statistical analysis was performed to determine correlations and significant differences.
Main Results:
- C3 levels were significantly lower in schistosomal patients compared to normal individuals.
- C3 levels were low in both HBsAg-negative and HBsAg-positive patients.
- No significant difference in C3 levels was observed based on HBsAg status or S. mansoni egg count (categorized as >400 or <400 eggs/1g).
- Ascites presence did not affect C3 concentration.
- A positive correlation was found between C3 and serum albumin levels.
Conclusions:
- Complement component C3 (C3) levels are reduced in patients with schistosomiasis, irrespective of HBsAg status or S. mansoni egg burden.
- Serum albumin may influence C3 levels in schistosomal patients.
- Further research is needed to understand the implications of C3 dysregulation in schistosomiasis and its impact on liver function.